| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
11,547 |
7,101 |
$371K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,599 |
15,820 |
$276K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
28,642 |
17,951 |
$189K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,746 |
2,535 |
$160K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,927 |
2,772 |
$100K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,905 |
1,722 |
$98K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,263 |
3,206 |
$88K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,216 |
4,612 |
$75K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,606 |
5,449 |
$70K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
9,074 |
7,569 |
$65K |
| G0378 |
Hospital observation service, per hour |
1,488 |
614 |
$63K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,570 |
4,242 |
$50K |
| 71046 |
Radiologic examination, chest; 2 views |
5,328 |
4,821 |
$45K |
| 80053 |
Comprehensive metabolic panel |
23,268 |
19,093 |
$43K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,805 |
4,438 |
$37K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
367 |
352 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,834 |
2,564 |
$33K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,368 |
7,763 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,451 |
4,954 |
$31K |
| 99215 |
Prolong outpt/office vis |
2,431 |
2,079 |
$28K |
| 96376 |
|
2,133 |
1,422 |
$28K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
961 |
631 |
$23K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
344 |
234 |
$21K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
418 |
384 |
$16K |
| 71045 |
Radiologic examination, chest; single view |
1,612 |
1,385 |
$15K |
| 73630 |
|
1,804 |
1,483 |
$15K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,521 |
1,202 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,479 |
7,142 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,034 |
6,593 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,353 |
2,826 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
30,365 |
23,882 |
$12K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,368 |
1,184 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,446 |
17,580 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,587 |
2,724 |
$11K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
255 |
235 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,277 |
2,820 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,753 |
1,136 |
$10K |
| 97162 |
|
785 |
711 |
$9K |
| 97161 |
|
1,147 |
1,096 |
$8K |
| 11721 |
|
1,289 |
718 |
$8K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,308 |
1,628 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
107 |
58 |
$7K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
422 |
396 |
$7K |
| 71250 |
|
71 |
69 |
$7K |
| J3490 |
Unclassified drugs |
368 |
255 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
134 |
116 |
$6K |
| 73030 |
|
353 |
324 |
$6K |
| 73562 |
|
378 |
336 |
$5K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,142 |
1,063 |
$5K |
| 85610 |
|
5,325 |
3,326 |
$5K |
| 84484 |
|
4,678 |
3,589 |
$5K |
| 96367 |
|
455 |
333 |
$4K |
| 73610 |
|
729 |
655 |
$4K |
| 83880 |
|
1,333 |
1,161 |
$4K |
| 73130 |
|
371 |
307 |
$4K |
| 72100 |
|
258 |
247 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
2,738 |
2,592 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
404 |
376 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,426 |
1,161 |
$3K |
| 73502 |
|
206 |
190 |
$3K |
| 82728 |
|
1,575 |
1,470 |
$3K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
13 |
13 |
$3K |
| 80069 |
|
775 |
641 |
$3K |
| 85027 |
|
4,591 |
4,182 |
$3K |
| 87088 |
|
3,948 |
3,579 |
$2K |
| 81001 |
|
6,418 |
5,560 |
$2K |
| 82043 |
|
758 |
732 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,320 |
2,985 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
177 |
144 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
533 |
358 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
7,666 |
6,200 |
$2K |
| 83735 |
|
3,540 |
2,841 |
$2K |
| 80061 |
Lipid panel |
6,494 |
6,214 |
$2K |
| 82607 |
|
1,145 |
1,071 |
$2K |
| 86140 |
|
2,530 |
2,123 |
$2K |
| 84439 |
|
1,279 |
1,195 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
267 |
234 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
352 |
316 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,186 |
3,313 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
361 |
291 |
$1K |
| 83550 |
|
1,385 |
1,290 |
$1K |
| 94760 |
|
286 |
157 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,010 |
1,479 |
$1K |
| 83605 |
|
2,439 |
1,986 |
$1K |
| 82805 |
|
788 |
626 |
$1K |
| 73110 |
|
98 |
85 |
$1K |
| 80051 |
|
2,756 |
2,406 |
$1K |
| 87040 |
|
1,510 |
1,158 |
$1K |
| 87186 |
|
1,783 |
1,606 |
$1K |
| 83540 |
|
1,505 |
1,403 |
$1K |
| 99217 |
|
382 |
334 |
$1K |
| 83690 |
|
4,395 |
3,692 |
$1K |
| 94644 |
|
92 |
79 |
$1K |
| 85651 |
|
1,998 |
1,662 |
$1K |
| 97116 |
|
422 |
171 |
$991.07 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,916 |
3,270 |
$878.85 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,752 |
1,443 |
$840.87 |
| 36410 |
|
23 |
15 |
$837.84 |
| 82565 |
|
3,155 |
2,722 |
$822.47 |
| 81003 |
|
3,556 |
3,248 |
$770.84 |
| J2060 |
Injection, lorazepam, 2 mg |
1,145 |
848 |
$698.50 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,280 |
700 |
$694.57 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
107 |
89 |
$691.39 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,081 |
915 |
$637.99 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
42 |
39 |
$631.71 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
46 |
26 |
$622.98 |
| 86803 |
|
702 |
651 |
$622.34 |
| 99219 |
|
111 |
108 |
$621.33 |
| 84520 |
|
2,980 |
2,567 |
$593.97 |
| 84460 |
|
935 |
899 |
$587.67 |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
34 |
12 |
$586.08 |
| 90715 |
|
98 |
81 |
$553.15 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
13 |
13 |
$532.71 |
| 82746 |
|
412 |
371 |
$508.67 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
794 |
531 |
$467.57 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17 |
17 |
$459.56 |
| 87077 |
|
863 |
759 |
$405.78 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,259 |
1,011 |
$393.01 |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,720 |
591 |
$386.53 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
18 |
14 |
$366.72 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
272 |
151 |
$341.77 |
| 80076 |
|
55 |
52 |
$313.91 |
| 84450 |
|
901 |
864 |
$270.84 |
| 85380 |
|
604 |
556 |
$250.25 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
437 |
339 |
$248.93 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
128 |
101 |
$247.52 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
88 |
64 |
$223.72 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
853 |
830 |
$213.93 |
| 97166 |
|
30 |
30 |
$201.79 |
| 81025 |
|
4,154 |
3,690 |
$159.62 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,691 |
2,457 |
$156.81 |
| 86352 |
|
165 |
140 |
$155.61 |
| 82248 |
|
820 |
677 |
$146.84 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32 |
27 |
$141.74 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
369 |
351 |
$141.56 |
| 82570 |
|
56 |
56 |
$139.07 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
437 |
320 |
$137.73 |
| 70498 |
|
12 |
12 |
$130.92 |
| 74019 |
|
16 |
12 |
$126.93 |
| 86618 |
|
13 |
13 |
$124.83 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
247 |
96 |
$114.12 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
172 |
166 |
$112.72 |
| 87081 |
|
1,265 |
1,197 |
$108.58 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
38 |
24 |
$102.98 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,964 |
1,833 |
$102.72 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,589 |
1,489 |
$100.78 |
| 85730 |
|
362 |
300 |
$99.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
338 |
288 |
$97.30 |
| 87205 |
|
371 |
309 |
$90.92 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
323 |
267 |
$88.81 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
30 |
28 |
$87.26 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
949 |
577 |
$84.14 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,589 |
1,489 |
$82.48 |
| 87070 |
|
204 |
184 |
$75.24 |
| 82947 |
|
2,209 |
1,962 |
$74.49 |
| 84100 |
|
260 |
228 |
$70.05 |
| 59025 |
Fetal non-stress test |
149 |
50 |
$69.59 |
| 80306 |
|
345 |
291 |
$69.55 |
| 85018 |
|
180 |
164 |
$68.11 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
111 |
100 |
$65.65 |
| 83970 |
|
16 |
14 |
$64.87 |
| J3480 |
Injection, potassium chloride, per 2 meq |
20 |
13 |
$63.11 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
25 |
25 |
$58.82 |
| 87147 |
|
584 |
526 |
$55.79 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
51 |
24 |
$48.42 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
20 |
18 |
$43.58 |
| 82040 |
|
289 |
271 |
$43.36 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
29 |
12 |
$43.01 |
| 81002 |
|
934 |
867 |
$41.77 |
| 86703 |
|
173 |
161 |
$40.24 |
| 99218 |
|
13 |
12 |
$38.96 |
| 76830 |
Ultrasound, transvaginal |
30 |
26 |
$37.83 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
15 |
12 |
$36.66 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
116 |
112 |
$35.34 |
| 83516 |
|
15 |
12 |
$30.80 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
1,384 |
1,283 |
$29.58 |
| 97035 |
|
78 |
43 |
$26.00 |
| 88142 |
|
402 |
388 |
$25.14 |
| 87340 |
|
108 |
103 |
$23.25 |
| 84075 |
|
272 |
258 |
$22.86 |
| 87581 |
|
369 |
351 |
$21.61 |
| 71271 |
|
25 |
25 |
$21.39 |
| 82247 |
|
277 |
249 |
$18.13 |
| 84156 |
|
28 |
25 |
$16.41 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
264 |
229 |
$15.66 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
21 |
19 |
$15.62 |
| Q3014 |
Telehealth originating site facility fee |
42 |
28 |
$14.93 |
| 84702 |
|
126 |
108 |
$13.75 |
| 82272 |
|
13 |
13 |
$13.18 |
| J1630 |
Injection, haloperidol, up to 5 mg |
17 |
13 |
$12.76 |
| 86850 |
|
26 |
25 |
$12.12 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
160 |
155 |
$9.86 |
| 86900 |
|
51 |
50 |
$6.75 |
| 86901 |
|
51 |
50 |
$6.67 |
| 86038 |
|
29 |
25 |
$5.98 |
| 84132 |
|
14 |
13 |
$5.39 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
104 |
100 |
$4.05 |
| 96368 |
|
15 |
14 |
$1.75 |
| J1790 |
Injection, droperidol, up to 5 mg |
13 |
13 |
$1.18 |
| 82010 |
|
15 |
12 |
$0.51 |
| 87210 |
|
15 |
14 |
$0.48 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
115 |
102 |
$0.01 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
75 |
71 |
$0.00 |
| 0002A |
|
60 |
60 |
$0.00 |
| 87660 |
|
93 |
88 |
$0.00 |
| 91300 |
|
133 |
133 |
$0.00 |
| 0071A |
|
39 |
38 |
$0.00 |
| 81000 |
|
55 |
52 |
$0.00 |
| 87480 |
|
93 |
88 |
$0.00 |
| 0012A |
|
457 |
451 |
$0.00 |
| 0011A |
|
330 |
325 |
$0.00 |
| 91301 |
|
795 |
752 |
$0.00 |
| 87510 |
|
93 |
88 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
54 |
52 |
$0.00 |
| 91307 |
|
75 |
74 |
$0.00 |
| 0001A |
|
72 |
72 |
$0.00 |
| 84703 |
|
28 |
26 |
$0.00 |
| 82150 |
|
16 |
13 |
$0.00 |
| 0072A |
|
36 |
36 |
$0.00 |